论文部分内容阅读
目的观察肠安方联合化疗治疗大肠癌根治术后的临床疗效。方法将80例大肠癌根治术后病例随机分为治疗组和对照组各40例,治疗组以肠安方联合化疗治疗,对照组给予单纯化疗;主要观察两组化疗完成率、患者生活质量、外周血白细胞、血小板计数、癌胚抗原(CEA)和复发转移情况。结果治疗组在提高化疗完成率、改善患者生活质量、减少血小板下降等方面均优于对照组(P<0.05)。结论肠安方联合化疗治疗大肠癌根治术后,有减轻化疗毒副反应、提高患者生活质量的作用。
Objective To observe the clinical efficacy of Chang’an combined with chemotherapy in the treatment of colorectal cancer after radical operation. Methods A total of 80 cases of colorectal cancer after radical operation were randomly divided into treatment group and control group, 40 cases in each group. The treatment group was treated with Changan combined with chemotherapy. The control group was given chemotherapy alone. The completion rate of chemotherapy, quality of life, Peripheral blood leucocytes, platelet count, carcinoembryonic antigen (CEA) and recurrence and metastasis. Results The treatment group was better than the control group (P <0.05) in improving the completion rate of chemotherapy, improving the quality of life of patients and reducing the platelet count. Conclusion The combination of chemotherapy and colorectal cancer treatment of colorectal cancer after radical surgery, reduce chemotherapy side effects and improve the quality of life of patients.